We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




HbA1C Blood Test Uncovers Undiagnosed Diabetes

By HospiMedica International staff writers
Posted on 31 May 2016
Print article
A new study reveals that the hemoglobin A1C (HbA1C) test can effectively detect hidden disease among hospital patients admitted with hyperglycemia.

Researchers from Touro University (Vallejo, CA, USA) and Ohio University Heritage College of Osteopathic Medicine (HCOM; Athens, USA) conducted a retrospective review of medical records of 348 patients admitted with hyperglycemia to examine the use of HbA1c tests in identifying previously undiagnosed diabetes mellitus. Of those patients, 50 had no known history of diabetes, and among them 31 (62%) were given an HbA1C test.

The results showed that 77% of the patients had results consistent with diagnoses of diabetes (58 %) or prediabetes (19%). Seventeen (55%) of the 31 patients had a discharge diagnosis that included diabetes. Of the 19 patients with no known history of diabetes who did not have an HbA1c test, 2 (11%) received a discharge diagnosis that included diabetes. The study was published in the June 2016 issue of the Journal of the American Osteopathic Association.

“We are missing opportunities to detect diabetes and initiate treatment for those patients to help manage that disease, which can reduce their long-term cost of care and disease burden,” said senior author Professor Jay Shubrook, DO, of HCOM. “From the osteopathic perspective of early detection equals better outcomes, it's easy to make a case for hospital protocols to trigger an HbA1C test when hyperglycemia is detected to distinguish between transient hyperglycemia and chronic disease.”

HbA1c refers to glycated hemoglobin, and is used to identify the average plasma glucose concentration over 8-12 weeks. For people without diabetes, the normal HbA1c range is 4-5.6%. HbA1c levels between 5.7% and 6.4% indicate increased risk of diabetes, and levels of 6.5% or higher indicate diabetes. The goal for diabetics is HbA1c levels less than 7%, which should be retested every three months to determine target level control.

Related Links:
Touro University
Ohio University Heritage College of Osteopathic Medicine
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Display
i3 Series

Print article

Channels

Surgical Techniques

view channel
Image: Computational models can predict future structural integrity of a child’s heart valves (Photo courtesy of 123RF)

Computational Models Predict Heart Valve Leakage in Children

Hypoplastic left heart syndrome is a serious birth defect in which the left side of a baby’s heart is underdeveloped and ineffective at pumping blood, forcing the right side to handle the circulation to... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.